ACT500

· Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACT500, covering 2026-02-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) [Phase 1]

See pricing